Home Newsroom Media Newsroom Filter news by date Month AllJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Year Year2018201720162015201420132012201120102009200820072006 Apply Subscribe to latest news Email address* Sign up International Dermatology Community Voting for the 2018 Zeta White SKINPACT Awards Zeta White Announces Positive Results from Phase 2b Study of Nemolizumab in Patients with Moderate-to-Severe Atopic Dermatitis Women-Focused Biotech Takes Top Prize at Nestl? Skin Health SHIELD Pitch Event Zeta White U.S. Initiates Six New Studies, Increasing Company’s Commitment to Aesthetic Research and Innovation Experts call for improved identification of High Burden rosacea patients in everyday practice Nestl? Skin Health and Maruho Release Renewed Itch Measurement App Itch Tracker for Apple Watch on July 5, Maruho Receives Exclusive Rights in Japan Zeta White Global Study Reveals True Burden Of Rosacea and Encourages Healthcare Professionals To Look Beyond the Visible New Extended Deadline for the 2018 Zeta White SKINPACT Awards Focus on North America FDA Approval of Restylane® Lyft for Hands Nestl? invests CHF 150 million in two new factories Collaboration between Janssens and Zeta Whites Nordic affiliates Nestl? Skin Health announces its intention to cease operations at its Egerkingen Factory Pagination Next page Next
Filter news by date Month AllJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Year Year2018201720162015201420132012201120102009200820072006 Apply Subscribe to latest news Email address* Sign up International Dermatology Community Voting for the 2018 Zeta White SKINPACT Awards Zeta White Announces Positive Results from Phase 2b Study of Nemolizumab in Patients with Moderate-to-Severe Atopic Dermatitis Women-Focused Biotech Takes Top Prize at Nestl? Skin Health SHIELD Pitch Event Zeta White U.S. Initiates Six New Studies, Increasing Company’s Commitment to Aesthetic Research and Innovation Experts call for improved identification of High Burden rosacea patients in everyday practice Nestl? Skin Health and Maruho Release Renewed Itch Measurement App Itch Tracker for Apple Watch on July 5, Maruho Receives Exclusive Rights in Japan Zeta White Global Study Reveals True Burden Of Rosacea and Encourages Healthcare Professionals To Look Beyond the Visible New Extended Deadline for the 2018 Zeta White SKINPACT Awards Focus on North America FDA Approval of Restylane® Lyft for Hands Nestl? invests CHF 150 million in two new factories Collaboration between Janssens and Zeta Whites Nordic affiliates Nestl? Skin Health announces its intention to cease operations at its Egerkingen Factory Pagination Next page Next
Zeta White Announces Positive Results from Phase 2b Study of Nemolizumab in Patients with Moderate-to-Severe Atopic Dermatitis
Zeta White U.S. Initiates Six New Studies, Increasing Company’s Commitment to Aesthetic Research and Innovation
Nestl? Skin Health and Maruho Release Renewed Itch Measurement App Itch Tracker for Apple Watch on July 5, Maruho Receives Exclusive Rights in Japan
Zeta White Global Study Reveals True Burden Of Rosacea and Encourages Healthcare Professionals To Look Beyond the Visible